Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chiusolo

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
MiCMA: an alternative treatment for refractory or recurrent Hodgkin's diseaseE O La Barbera, P Chiusolo, L Laurenti, et al.
Heart (British Cardiac Society)|April 16, 2004
Glycoprotein Ia C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow upA M Leone, V De Stefano, F Burzotta, et al.
Bone Marrow Transplantation|March 15, 2011
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxisP Chiusolo, S Bellesi, N Piccirillo, et al.
Leukemia|September 12, 2012
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseasesM T Voso, E Fabiani, L Fianchi, et al.
Bone Marrow Transplantation|June 6, 2023
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxisJ D Marra, E Galli, S Giammarco, et al.
The Pharmacogenomics Journal|May 8, 2013
The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancerM M Hagleitner, M J H Coenen, R Aplenc, et al.
Bone Marrow Transplantation|May 29, 2007
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infectionP de Fabritiis, A Spagnoli, P Di Bartolomeo, et al.
Bone Marrow Transplantation|November 20, 2024
The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experienceS Giammarco, R Maggi, Luca Di Marino, et al.
Bone Marrow Transplantation|January 10, 2017
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)E Todisco, F Ciceri, C Boschini, et al.
ESMO Open|November 19, 2025
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric surveyM Turinetto, C Marchetti, G Scandurra, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
MiCMA: an alternative treatment for refractory or recurrent Hodgkin's diseaseE O La Barbera, P Chiusolo, L Laurenti, et al.
Heart (British Cardiac Society)|April 16, 2004
Glycoprotein Ia C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow upA M Leone, V De Stefano, F Burzotta, et al.
Bone Marrow Transplantation|March 15, 2011
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxisP Chiusolo, S Bellesi, N Piccirillo, et al.
Leukemia|September 12, 2012
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseasesM T Voso, E Fabiani, L Fianchi, et al.
Bone Marrow Transplantation|June 6, 2023
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxisJ D Marra, E Galli, S Giammarco, et al.
The Pharmacogenomics Journal|May 8, 2013
The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancerM M Hagleitner, M J H Coenen, R Aplenc, et al.
Bone Marrow Transplantation|May 29, 2007
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infectionP de Fabritiis, A Spagnoli, P Di Bartolomeo, et al.
Bone Marrow Transplantation|November 20, 2024
The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experienceS Giammarco, R Maggi, Luca Di Marino, et al.
Bone Marrow Transplantation|January 10, 2017
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)E Todisco, F Ciceri, C Boschini, et al.
ESMO Open|November 19, 2025
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric surveyM Turinetto, C Marchetti, G Scandurra, et al.
Pageof 9